Switchover study from Botox to Xeomin for facial dystonia
7 April 2021
| Ivan Yip
|
Neuro-Ophthalmology
|
facial dystonia, incobotulinumtoxinA, onabotulinumtoxinA
This study carried out in the UK compared the clinical effectiveness and efficiency of switching patients from Botox® injections to Xeomin®. This was carried out in 20 essential blepharospasm, 12 hemifacial spasm and six aberrant facial nerve regeneration patients. Patients...